METTL3-MEDIATED M6A MODIFICATION OF SIGMAR1 MRNA PROMOTES PODOCYTE GLYCOLYSIS IN DIABETIC NEPHROPATHY
Back
Abstract Number
WCN23-0842
Categories
Chronic Kidney Disease, Hypertension, Diabetes and CVD
Topic - Chronic Kidney Disease, Hypertension, Diabetes and CVD
Diabetic Kidney Disease, Drugs and Treatments
Topic - AKI, Electrolytes, Acid-base Disorders, Tropical Diseases, RPGN and Pregnancy
Topic - Kidney Failure (Former ESKD), incl. Dialysis, Transplantation, Conservative Care
Topic - Special Covid-19
Topic - Education
Abstract Title
METTL3-MEDIATED M6A MODIFICATION OF SIGMAR1 MRNA PROMOTES PODOCYTE GLYCOLYSIS IN DIABETIC NEPHROPATHY
Co-authors
Jiang, L.(1)*;Wu, Y.(1);
ie:
Azwin Z.1, Siti Y.1, John D.2
Institution
(1)The First Affiliated Hospital- Anhui Medical University, Nephropathy, Hefei, China;
E-Poster
https://storage.unitedwebnetwork.com/files/1041/37c5e74f6f3e82f1c1c353f38f9697ed.ppt
Audio File
if any